ADMA Biologics, Inc. (ADMA)
NASDAQ: ADMA · Real-Time Price · USD
17.93
-0.02 (-0.11%)
At close: Jan 12, 2026, 4:00 PM EST
17.85
-0.08 (-0.45%)
After-hours: Jan 12, 2026, 7:53 PM EST
ADMA Biologics Market Cap
ADMA Biologics has a market cap or net worth of $4.27 billion as of January 12, 2026. Its market cap has increased by 1.87% in one year.
Market Cap
4.27B
Enterprise Value
4.29B
1-Year Change
1.87%
Ranking
Category
Stock Price
$17.93
Market Cap Chart
Since October 17, 2013, ADMA Biologics's market cap has increased from $50.20M to $4.27B, an increase of 8,400.60%. That is a compound annual growth rate of 43.77%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 9, 2026 | 4.27B | -1.59% |
| Dec 31, 2025 | 4.34B | 7.08% |
| Dec 31, 2024 | 4.05B | 296.92% |
| Dec 29, 2023 | 1.02B | 33.78% |
| Dec 30, 2022 | 763.50M | 176.53% |
| Dec 31, 2021 | 276.10M | 49.73% |
| Dec 31, 2020 | 184.40M | -22.29% |
| Dec 31, 2019 | 237.30M | 114.17% |
| Dec 31, 2018 | 110.80M | -12.41% |
| Dec 29, 2017 | 126.50M | 91.67% |
| Dec 30, 2016 | 66.00M | -23.70% |
| Dec 31, 2015 | 86.50M | -16.67% |
| Dec 31, 2014 | 103.80M | 44.37% |
| Dec 31, 2013 | 71.90M | 43.23% |
| Oct 17, 2013 | 50.20M | - |
View and export this data all the way back to 2013. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 952.29B |
| Johnson & Johnson | 492.44B |
| AbbVie | 388.97B |
| UnitedHealth Group | 311.59B |
| AstraZeneca | 295.57B |
| Merck & Co. | 274.34B |
| Novartis AG | 272.98B |
| Novo Nordisk | 263.81B |